No Data
No Data
Five Reasons Why UBS Is Overweight the UK
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week
Have Verona Pharma Insiders Been Selling Stock?
Insider Sale: Chief Financial Officer of $VRNA (VRNA) Sells 12,936 Shares
Jefferies Maintains Verona Pharma(VRNA.US) With Buy Rating, Raises Target Price to $50
Verona Pharma Announces December 2024 Investor Conference Participation
loading...
loading...